The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Neurocysticercosis


Psychiatry related information on Neurocysticercosis


High impact information on Neurocysticercosis


Chemical compound and disease context of Neurocysticercosis


Biological context of Neurocysticercosis


Anatomical context of Neurocysticercosis


Gene context of Neurocysticercosis


Analytical, diagnostic and therapeutic context of Neurocysticercosis


  1. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Medina, M.T., Rosas, E., Rubio-Donnadieu, F., Sotelo, J. Arch. Intern. Med. (1990) [Pubmed]
  2. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Garcia, H.H., Gilman, R.H., Horton, J., Martinez, M., Herrera, G., Altamirano, J., Cuba, J.M., Rios-Saavedra, N., Verastegui, M., Boero, J., Gonzalez, A.E. Neurology (1997) [Pubmed]
  3. Large cerebral infarction during praziquantel therapy in neurocysticercosis. Bang, O.Y., Heo, J.H., Choi, S.A., Kim, D.I. Stroke (1997) [Pubmed]
  4. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Garcia, H.H., Gonzalez, A.E., Gilman, R.H., Bernal, T., Rodriguez, S., Pretell, E.J., Azcurra, O., Parkhouse, R.M., Tsang, V.C., Harrison, L.J. Am. J. Trop. Med. Hyg. (2002) [Pubmed]
  5. Taenia solium taeniasis and neurocysticercosis in a Mexican rural family. Lara-Aguilera, R., Mendoza-Cruz, J.F., Martinez-Toledo, J.L., Macias-Sanchez, R., Willms, K., Altamirano-Rojas, L., Santamaria-Llano, A. Am. J. Trop. Med. Hyg. (1992) [Pubmed]
  6. Neurocysticercosis: an update. Carpio, A. The Lancet infectious diseases. (2002) [Pubmed]
  7. Neurocysticercosis in an Orthodox Jewish community in New York City. Schantz, P.M., Moore, A.C., Muñoz, J.L., Hartman, B.J., Schaefer, J.A., Aron, A.M., Persaud, D., Sarti, E., Wilson, M., Flisser, A. N. Engl. J. Med. (1992) [Pubmed]
  8. Neurocysticercosis and epilepsy. O'Donoghue, M., Sander, J.W. Lancet (1993) [Pubmed]
  9. Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis. Uddin, J., Garcia, H.H., Gilman, R.H., Gonzalez, A.E., Friedland, J.S. J. Immunol. (2005) [Pubmed]
  10. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Carpio, A., Santillán, F., León, P., Flores, C., Hauser, W.A. Arch. Intern. Med. (1995) [Pubmed]
  11. Albendazole therapy for neurocysticercosis. Escobedo, F., Penagos, P., Rodriguez, J., Sotelo, J. Arch. Intern. Med. (1987) [Pubmed]
  12. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Vazquez, M.L., Jung, H., Sotelo, J. Neurology (1987) [Pubmed]
  13. Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis. Paias, F.O., Lanchote, V.L., Takayanagui, O.M., Bonato, P.S. Electrophoresis (2001) [Pubmed]
  14. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. Dachman, W.D., Adubofour, K.O., Bikin, D.S., Johnson, C.H., Mullin, P.D., Winograd, M. J. Infect. Dis. (1994) [Pubmed]
  15. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Sotelo, J., Jung, H. Clinical pharmacokinetics. (1998) [Pubmed]
  16. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial. Medina, M.T., Genton, P., Montoya, M.C., Córdova, S., Dravet, C., Sotelo, J. Epilepsia (1993) [Pubmed]
  17. Solitary neurocysticercosis case caused by Asian genotype of Taenia solium confirmed by mitochondrial DNA analysis. Yamasaki, H., Matsunaga, S., Yamamura, K., Chang, C.C., Kawamura, S., Sako, Y., Nakao, M., Nakaya, K., Ito, A. J. Clin. Microbiol. (2004) [Pubmed]
  18. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. Jung, H., Hurtado, M., Sanchez, M., Medina, M.T., Sotelo, J. Journal of clinical pharmacology. (1992) [Pubmed]
  19. Oncospheral peptide-based ELISAs as potential seroepidemiological tools for Taenia solium cysticercosis/neurocysticercosis in Venezuela. Ferrer, E., Cortéz, M.M., Cabrera, Z., Rojas, G., Dávila, I., Alarcón de Noya, B., Pérez, H.A., Fernandez, I., Romero, H.U., Harrison, L.J., Parkhouse, R.M., Gárate, T. Trans. R. Soc. Trop. Med. Hyg. (2005) [Pubmed]
  20. Possible association between Taenia solium cysticercosis and cancer: increased frequency of DNA damage in peripheral lymphocytes from neurocysticercosis patients. Herrera, L.A., Ramirez, T., Rodríguez, U., Corona, T., Sotelo, J., Lorenzo, M., Ramos, F., Verdorfer, I., Gebhart, E., Ostrosky-Wegman, P. Trans. R. Soc. Trop. Med. Hyg. (2000) [Pubmed]
  21. Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Wichert-Ana, L., Velasco, T.R., Terra-Bustamante, V.C., Alexandre, V., Walz, R., Bianchin, M.M., Leite, J.P., Assirati, J.A., Carlotti, C.G., Araújo, D., Santos, A.C., Takayanagui, O.M., Sakamoto, A.C. Arch. Neurol. (2004) [Pubmed]
  22. Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis. Pardini, A.X., Vaz, A.J., Dos Ramos Machado, L., Livramento, J.A. J. Clin. Microbiol. (2001) [Pubmed]
  23. Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Chavarría, A., Fleury, A., García, E., Márquez, C., Fragoso, G., Sciutto, E. Clin. Immunol. (2005) [Pubmed]
  24. Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Restrepo, B.I., Aguilar, M.I., Melby, P.C., Teale, J.M. Am. J. Trop. Med. Hyg. (2001) [Pubmed]
  25. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. Proaño, J.V., Madrazo, I., García, L., García-Torres, E., Correa, D. J. Neurosurg. (1997) [Pubmed]
  26. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Evans, C.A., Garcia, H.H., Hartnell, A., Gilman, R.H., Jose, P.J., Martinez, M., Remick, D.G., Williams, T.J., Friedland, J.S. Infect. Immun. (1998) [Pubmed]
  27. Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis. Rodrigues, V., de-Mello, F.A., Magalhães, E.P., Ribeiro, S.B., Marquez, J.O. Braz. J. Med. Biol. Res. (2000) [Pubmed]
  28. Detection of glial fibrillary acidic protein and neurofilaments in the cerebrospinal fluid of patients with neurocysticercosis. Quintanar, J.L., Franco, L.M., Salinas, E. Parasitol. Res. (2003) [Pubmed]
  29. Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy. Portela, L.V., Tort, A.B., Walz, R., Bianchin, M., Trevisol-Bittencourt, P.C., Wille, P.R., Cardoso, R.C., Ishida, M.M., vonWangenheim, A., Grisard, E.C., Steindel, M., Gonçalves, C.A., Souza, D.O. Acta neurologica Scandinavica. (2003) [Pubmed]
  30. Epilepsy due to neurocysticercosis: analysis of 203 patients. Del Brutto, O.H., Santibañez, R., Noboa, C.A., Aguirre, R., Díaz, E., Alarcón, T.A. Neurology (1992) [Pubmed]
  31. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. Wilson, M., Bryan, R.T., Fried, J.A., Ware, D.A., Schantz, P.M., Pilcher, J.B., Tsang, V.C. J. Infect. Dis. (1991) [Pubmed]
  32. Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples. Bueno, E.C., Vaz, A.J., Machado, L.D., Livramento, J.A., Mielle, S.R. J. Clin. Microbiol. (2000) [Pubmed]
  33. Discrimination between active and inactive neurocysticercosis by metacestode excretory/secretory antigens of Taenia solium in an enzyme-linked immunosorbent assay. Molinari, J.L., García-Mendoza, E., de la Garza, Y., Ramírez, J.A., Sotelo, J., Tato, P. Am. J. Trop. Med. Hyg. (2002) [Pubmed]
WikiGenes - Universities